Journey101 Home PageArticles


HomeSite MapMail




TESTING TREATMENTS

TESTING TREATMENTS - BETTER RESEARCH
FOR BETTER HEALTHCARE


By Imogen Evans, Hazel Thornton, and Iain Chalmers


REFERENCES 61-90

61 Goodare H. Studies that do not have informed consent from participants should not
be published. In: Doyal L, Tobias JS, eds. Informed consent in medical research. BMJ
Books 2001, pp131–3.

62 Fallowfield L, Jenkins V, Farewell V, et al. Efficacy of a Cancer Research UK
communicating skills training model for oncologists: a randomised controlled trial.
Lancet 2002;359:650–6.

63 Tobias J, Souhami R. Fully informed consent can be needlessly cruel. British Medical
Journal 1993;307:119–20.

64 Baum, M. The ethics of randomised controlled trials. European Journal of Surgical
Oncology 1995;21:136–7.

65 Thornton H. Why do we need clinical trials? BACUP News; issue 30, autumn 1997, p7.

66 de Takats P, Harrison J. Clinical trials and stroke. Lancet 1999;353:150.

67 Chalmers I, Lindley R. Double standards on informed consent to treatment. In: Doyal L, Tobias JS, eds. Informed consent in medical research. London: BMJ Books 2001, pp266–75.

68 Ashcroft, R. Giving medicine a fair trial. British Medical Journal 2000;320:1686.

69 Savulescu J, Chalmers I, Blunt J. Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability. British Medical Journal 1996;313:1390–3.

70 European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379–87.

71 Cina CS, Clase CM, Haynes RB. Carotid endarterectomy for symptomatic carotid
stenosis. The Cochrane Database of Systematic Reviews 1999, Issue 3. Art. No.:
CD001081. Available from: www.thecochranelibrary.com [accessed 3 January
2006].

72 The Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised, placebocontrolled trial. Lancet 2002;359:1877–90.

73 Duley L, Gu¨ lmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other
anticonvulsants for women with pre-eclampsia. The Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD000025. Available from:
www.thecochranelibrary.com [accessed 3 January 2006].

74 Grimwade K, Swingler, G, Grimley Evans J. Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV. The Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD003108. Available from: www.thecochranelibrary.com [accessed 3 Jan. 2006].

75 Chintu C, Bhat GJ, Walker AS, et al. Co-trimoxazole as prophylaxis against
opportunistic infections in HIV-infected Zambian children (CHAP): a double blind
randomised placebo-controlled trial. Lancet 2004;364:1865–71.

76 MRC News Release. Antibiotic drug almost halves AIDS-related death in children.
London: MRC, November 19, 2004.

77 Soares K, McGrath J, Adams C. Evidence and tardive dyskinesia. Lancet
1996;347:1696–7.

78 Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia
over 50 years. British Medical Journal 1998;317:1181–4.

79 Howell CJ, Chalmers I. A review of prospectively controlled comparisons of epidural
with non-epidural forms of pain relief during labour. International Journal of Obstetric
Anesthesia 1992;1:93–110.

80 Chan A-W, Hro´ bjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. Journal of the American Medical Association 2004;291:2457–65.

81 Horn J, de Haan RJ, Vermeulen RD, Luiten PGM, Limburg M. Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke 2001;32:2433–8.

82 Lau J, Schmid CH, Chalmers TC. Cumulative meta-analysis of clinical trials builds evidence of exemplary clinical practice. Journal of Clinical Epidemiology 1995;48: 45–57.

83 Altman DG. The scandal of poor medical research. British Medical Journal 1994;308:283–4.

84 Tallon D, Chard J, Dieppe P. Relation between agendas of the research community and the research consumer. Lancet 2000;355:2037–40.

85 Cream J, Cayton H. New drugs for Alzheimer’s disease – a consumer perspective. CPD Bulletin Old Age Psychiatry 2001;2:80–2.

86 Cohen CI, D’Onofrio A, Larkin L, Berkholder P, Fishman H. A comparison of consumer and provider preferences for research on homeless veterans. Community Mental Health Journal 1999;35:273–9.

87 Griffiths KM, Jorm AF, Christensen H, et al. Research priorities in mental health, Part 2: an evaluation of the current research effort against stakeholders’ priorities. Australian and New Zealand Journal of Psychiatry 2002;36:327–39.

88 Chalmers I. Current controlled trials: an opportunity to help improve the quality of clinical research. Current Controlled Trials in Cardiovascular Medicine 2000;1:3–8. Available from : http://cvm.controlled-trials.com/content/1/1/3 [accessed 12 December 2005].

89 Safeguarding participants in controlled trials [Editorial]. Lancet 2000;355:1455–63.

90 Weatherall D. Academia and industry: increasingly uneasy bedfellows. Lancet 2000;355:1574.






Designed and Powered by RomWell.net
>